Immunological markers of rheumatoid arthritis
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue
Abstract
Rheumatoid arthritis (RA) is the most common connective tissue disease of autoimmune origin. The disease is characterized by chronic inflammation leading to bone erosions and organ involvement. RA is a progressive disease. It affects the quality of life, leading to disability and death mainly due to premature cardiovascular disease. Early diagnosis and appropriate treatment are essential for prognosis and quality of life improvement.In 2010 the American College of Rheumatology (ACR) and The European League Against Rheumatism (EULAR) established new RA classification criteria. Besides clinical symptoms it includes two immunologic criteria: rheumatoid factor (RF) and anti-citrullinated protein antibodies (anti-CCP antibodies). RF is the first well-known RA immunologic marker. It is observed in 80-85% of patients with RA. Elevated serum level of RF has been associated with increased disease activity, radiographic progression, and the presence of extraarticular manifestations. The sensitivity of RF is 50-90%, and specificity is 50-95%. Anti-CCP antibodies appear to be a more specific marker than RF. They are often present at the very beginning of the disease, or even years before the first symptoms. The prognostic value of anti-CCP antibodies is well established. High serum level of anti-CCP correlates with poor prognosis and early erosions of the joints. The sensitivity of anti-CCP2 is 48-80%, and specificity is 96-98%.New immunologic markers include anti-carbamylated protein antibodies (anti-CarP) and antibodies against heterogeneous nuclear ribonucleoproteins (anti-hnRNP A2/B1, RA33). Scientists aim to identify a highly sensitive and specific biomarker of the disease that not only has diagnostic and prognostic value but also may predict the response to treatment.
Authors and Affiliations
Agnieszka Matuszewska, Marta Madej, Piotr Wiland
Keywords
Related Articles
- EP ID EP220745
- DOI -
- Views 135
- Downloads 0
Dysfunkcje lizosomów a choroby neurodegeneracyjne
Recent data advocate for the implication of lysosomes in the development of programmed cell death. Lysosomal dysfunction decreased the efficiency of autophagosome/lysosome fusion that leads to vacuolation of cells. Autop...
Well-known and new variants of pathogenic Escherichia coli as a consequence of the plastic genome
E. coli is a diverse bacterial species encompassing commensal as well as intestinal and extraintestinal pathogenic strains. The ability to adapt to so many different niches in the host organism is determined by the extre...
Fizjologiczna rola nukleobindyny-2/nesfatyny-1 oraz ich potencjalne znaczenie kliniczne
Nukleobindyna-2 jest wielodomenowym białkiem, z którego w procesie proteolizy mogą powstawać trzy produkty białkowe: nesfatyna-1, -2 oraz -3. Nukleobindyna-2 oraz nesfatyna-1 hamują uczucie łaknienia u gryzoni. W artykul...
Kopeptyna – stabilny peptyd C-końcowy preprowazopresyny jako nowy marker stresu u noworodka
Bodźce stresowe, w tym choroby, zaburzają homeostazę ustroju i stymulują wydzielanie wielu hormonów zależnych od pobudzenia podwzgórza, przysadki i nadnerczy. Jednym z ważniejszych hormonów podwzgórzowych wydzielanych w...
Rola sierocych receptorów jądrowych w rozwoju limfocytów T w grasicy
Proces dojrzewania prekursorów limfocytów T w grasicy (tymocytów) składa się z kolejnych etapów różnicowania, selekcji i ekspansji tymocytów. W procesie dojrzewania tymocytów można wyróżnić dwa punkty kontrolne, w któryc...